Target intelligence / Profile preview

Trypanosoma cruzi glycoprotein gp72 (gp72)

Target
gp72
Molecular classification
Glycoprotein, Surface antigen, Protozoan protein
01

Overview

Glycoprotein gp72 is a low-abundance, highly glycosylated surface protein found on *Trypanosoma cruzi*, predominantly in the epimastigote form within the insect vector. It contains one of the most complex eukaryotic phosphosaccharide structures, with a carbohydrate composition of about 50% by weight. The glycan chains are linked via phosphodiester bonds to threonine and serine residues. gp72 is localized to the flagellar adhesion zone, where it is essential for flagellar attachment and infectivity. It is immunogenic and carries the WIC29.26 epitope. Ligation with its cognate antibody inhibits differentiation, suggesting its role as a developmental and functional surface marker. Its expression is stage-specific and important for parasite virulence. While it is vital for the parasite's biology, there are currently no therapeutic agents directly targeting gp72, and its potential as a therapeutic target remains under study[1][2][4][5].

Other names
GP72 antigenGp7272 kDa glycoprotein
02

Biological functions

Flagellar adhesionParasite differentiation (prevents conversion from epimastigote to trypomastigote)Surface antigenicity
03

Disease associations

Infection (crucial in the life cycle of Trypanosoma cruzi, causative agent of Chagas disease)
04

Biomarkers

WIC29.26 carbohydrate epitope

Beyond the preview

Go deeper on Trypanosoma cruzi glycoprotein gp72 (gp72).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trypanosoma cruzi glycoprotein gp72 (gp72).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call